Immunitybio, Inc.
IBRX
Revenue
1.05M
▲1.01M▲2517.50%
3 Months ChangeAssets
444.33M
▲43.65M▲10.89%
3 Months ChangeLiabilities
1.14B
▲50.04M▲4.58%
3 Months ChangeFree Cash Flow
-108.24M
▼-15.51M▼-16.72%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0001326110-24-000103
2024-07-18
Form 8-K
ID: 0001326110-24-000093
2024-06-12
Form 8-K
ID: 0001326110-24-000069
2024-05-09
Form 10-Q
ID: 0001326110-24-000064
2024-04-23
Form 8-K
ID: 0001326110-24-000040
2024-02-26
Form 8-K
ID: 0001193125-24-044886
2024-01-02
Form 8-K
ID: 0001326110-24-000003
2023-11-09
Form 10-Q
ID: 0001326110-23-000147
2023-09-11
Form 8-K
ID: 0001326110-23-000121
2023-09-01
Form 8-K
ID: 0001326110-23-000112